Calidi Biotherapeutics Inc

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
Analyst consensus
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Calidi Biotherapeutics Inc
Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered enveloped oncolytic virus designed for systemic delivery and targeting of metastatic sites. Its technology is intended to shield the virus from immune clearance, allowing virotherapy to effectively reach tumor sites, induce tumor lysis, and deliver potent genetic medicine(s) to metastatic locations. Its product candidates include The RedTail for Metastatic Solid Tumors, CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-101 (NeuroNova) for Newly Diagnosed High Grade Glioma.
Frequently asked questions
You need to open and fund a Saxo account to buy Calidi Biotherapeutics Inc stock. Once the account is approved, you can login to the platform (SaxoInvestor or SaxoTrader), search for Calidi Biotherapeutics Inc (by name) or ‘APPL’ (by ticker), choose the number of shares you wish to buy, and place your order.
The ticker symbol for Calidi Biotherapeutics Inc is CLDI:xase. You can use this code to find the stock in our platforms and track its price and performance.
Calidi Biotherapeutics Inc has its primary listing on NYSE American. You can trade Calidi Biotherapeutics Inc with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Calidi Biotherapeutics Inc is available to trade on SaxoInvestor and SaxoTrader. You can buy Calidi Biotherapeutics Inc stock directly and include it as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Calidi Biotherapeutics Inc or others.